Table 1 Human ovarian cancer tissue samples staining either positive or negative for PRL-3 expression, as analyzed by immunohistochemistry
From: PRL-3 suppresses c-Fos and integrin α2 expression in ovarian cancer cells
Histo-pathology | PRL-3 positive | PRL-3 negative | % PRL-3 positive |
|---|---|---|---|
Normal | 0 | 14 | 0 |
Serous cystadenocarcinoma (ovary) | 19 | 64 | 29.7 |
Serous cystadenocarcinoma (LN metastasis) | 0 | 10 | 0 |
Mucinous cystadenoma | 1 | 18 | 5.6 |
Endometriod adenocarcinoma | 5 | 23 | 21.7 |
Clear cell carcinoma | 0 | 5 | 0 |
Undifferentiated carcinoma | 0 | 3 | 0 |
Others * | 1 | 12 | 8.3 |
Total | 26 | 149 | 17.5 |